Search details
1.
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.
Lancet Infect Dis
; 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38614117
2.
Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial.
Lancet Reg Health West Pac
; 34: 100707, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37283962
Results
1 -
2
de 2
1
Next >
>>